Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Creighton, Chad J ^a   Hernandez Herrera, Anadulce ^g   Jacobsen, Anders ^b   Levine, Douglas A ^b   Mankoo, Parminder ^b   Schultz, Nikolaus ^b   Du, Ying ^c   Zhang, Yiqun ^a   Larsson, Erik ^b   Sheridan, Robert ^b   Xiao, Weimin ^g   Spellman, Paul T ^e   Getz, Gad ^f   Wheeler, David A ^a   Perou, Charles M ^c   Gibbs, Richard A ^a   Sander, Chris ^b   Hayes, D Neil ^c,d   Gunaratne, Preethi H ^a,g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN29 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; DNMT3A GENE; DNMT3B GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ALGORITHM; GENETIC DATABASE; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HEMIZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ONCOGENE; OVARY CARCINOMA; OVERALL SURVIVAL; RNA METHYLATION; SEROSA; BREAST; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BREAST; CELL LINE, TUMOR; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; OVARIAN NEOPLASMS;

EID: 84859090208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034546     Document Type: Article

References (37)

1. Guo H, Ingolia N, Weissman J, Bartel D, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
2. Iorio M, Croce C, (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856.
3. Wu L, Belasco J, (2008) Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell 29: 1-7.
4. John B, Enright A, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
5. Rajewsky N, (2006) microRNA target predictions in animals. Nat Genet 38 (Suppl).
6. Lewis B, Shih I, Jones-Rhoades M, Bartel D, Burge C, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
7. Friedman R, Farh K, Burge C, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
8. The_Cancer_Genome_Atlas_Research_Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615.
9. Iorio M, Visone R, Di Leva G, Donati V, Petrocca F, et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707.
10. Creighton C, Fountain M, Yu Z, Nagaraja A, Zhu H, et al. (2010) Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res 70: 1906-1915.
11. Bearfoot J, Choong D, Gorringe K, Campbell I, (2008) Genetic analysis of cancer-implicated MicroRNA in ovarian cancer. Clin Cancer Res 14: 7246-7250.
12. Nam E, Yoon H, Kim S, Kim H, Kim Y, et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695.
13. Zhang L, Volinia S, Bonome T, Calin G, Greshock J, et al. (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 105: 7004-7009.
14. Wyman S, Parkin R, Mitchell P, Fritz B, O'Briant K, et al. (2009) Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 4: e5311.
15. Baskerville S, Bartel D, (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11: 241-247.
16. Pollack J, Sørlie T, Perou C, Rees C, Jeffrey S, et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 99: 12963-12968.
17. Wang Y, Li K, (2009) Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data. BMC Genomics 10: 218.
18. Liang Y, Ridzon D, Wong L, Chen C, (2007) Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8: 166.
19. Shih K, Qin L, Tanner E, Zhou Q, Bisogna M, et al. (2011) A microRNA survival signature (MiSS) for advanced ovarian cancer. Gynecol Oncol 121: 444-450.
20. Merritt W, Lin Y, Han L, Kamat A, Spannuth W, et al. (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650.
21. Mankoo P, Shen R, Schultz N, Levine D, Sander C, (2011) Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles. PLoS One 6: e24709.
22. Zhou X, Zhao F, Wang Z, Song Y, Chang H, et al. (2011) Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncol Rep E-pub Oct 3.
23. Liu X, Li X, Zhang B, Liang Y, Zhou C, et al. (2011) MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett 585: 1363-1367.
24. Forman J, Legesse-Miller A, Coller H, (2008) A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 105: 14879-14884.
25. Tay Y, Zhang J, Thomson A, Lim B, Rigoutsos I, (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
26. Lee I, Ajay S, Yook J, Kim H, Hong S, et al. (2009) New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Res 19: 1175-1183.
27. Lytle J, Yario T, Steitz J, (2007) Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc Natl Acad Sci U S A 104: 9667-9672.
28. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104: 15805-15810.
29. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy C, et al. (2009) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113: 6411-6418.
30. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
31. Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
32. TCGA Data Portal website. Available: http://tcga-data.nci.nih.gov/tcga/. Accessed 2010 Nov.
33. Saldanha AJ, (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
34. Betel D, Wilson M, Gabow A, Marks D, Sander C, (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149-153.
35. Creighton C, Nagaraja A, Hanash S, Matzuk M, Gunaratne P, (2008) A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA 14: 2290-2296.
36. cBio Cancer Genomics Portal website. Available: http://www.cbioportal.org/. Accessed 2011 Nov.
37. Jacobsen A, Wen J, Marks D, Krogh A, (2010) Signatures of RNA binding proteins globally coupled to effective microRNA target sites. Genome Res 20: 1010-1019.